Skip to main content
Springer logoLink to Springer
. 2025 Feb 15;68(4):902. doi: 10.1007/s00125-025-06372-z

Correction: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans

Elise Wreven 1, María Soledad Ruiz de Adana 2,3, Stéphan Hardivillé 4, Valery Gmyr 1, Julie Kerr-Conte 1, Mikael Chetboun 1, Gianni Pasquetti 1, Nathalie Delalleau 1, Julien Thévenet 1, Anaïs Coddeville 1, María José Vallejo Herrera 2, Liad Hinden 5, Inmaculada Concepción Benavides Espínola 2, Mireia Gómez Duro 1, Lourdes Sanchez Salido 2, Francisca Linares 2,3, Francisco-Javier Bermúdez-Silva 2,3, Joseph Tam 5, Caroline Bonner 1, Josephine M Egan 6, Gabriel Olveira 2,3,7, Natalia Colomo 2,3, François Pattou 1, Isabel González-Mariscal 1,2,3,8,✉
PMCID: PMC11950003  PMID: 39954060

Correction: Diabetologia (2024) 67:1877-1896

10.1007/s00125-024-06193-6

Acknowledgment of funding for the project PID2021-128926OA-I00 by MICIU/AEI/10.13039/501100011033 and UE was omitted in the Funding section.

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Diabetologia are provided here courtesy of Springer

RESOURCES